Logo image of LRN

STRIDE INC (LRN) Stock Analyst Ratings

NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD

159.55  +8.85 (+5.87%)

After market: 159.007 -0.54 (-0.34%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 146.63. This target is -8.1% below the current price.
LRN was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 9 analysts. More opinions would make the average more meaningful.
LRN Historical Analyst RatingsLRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 159.55140.39145.86146.63157.50 - -12.01% -8.58% -8.10% -1.28%
LRN Current Analyst RatingLRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-04-30 Barrington Research Maintains Outperform -> Outperform
2025-04-28 Canaccord Genuity Maintains Buy -> Buy
2025-04-17 Barrington Research Maintains Outperform -> Outperform
2025-04-01 BMO Capital Maintains Outperform -> Outperform
2025-03-14 Barrington Research Maintains Outperform -> Outperform
2025-03-11 Canaccord Genuity Maintains Buy -> Buy
2025-01-30 BMO Capital Maintains Outperform -> Outperform
2025-01-29 Barrington Research Maintains Outperform -> Outperform
2025-01-29 Canaccord Genuity Maintains Buy -> Buy
2025-01-27 Canaccord Genuity Maintains Buy -> Buy
2025-01-17 Barrington Research Maintains Outperform -> Outperform
2024-12-12 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-10-29 Citigroup Maintains Neutral -> Neutral
2024-10-24 BMO Capital Maintains Outperform -> Outperform
2024-10-23 Barrington Research Maintains Outperform -> Outperform
2024-10-23 Canaccord Genuity Maintains Buy -> Buy
2024-10-11 Barrington Research Maintains Outperform -> Outperform
2024-09-20 Barrington Research Maintains Outperform -> Outperform
2024-08-20 Citigroup Downgrade Buy -> Neutral
2024-08-08 Barrington Research Maintains Outperform -> Outperform
2024-08-08 BMO Capital Maintains Outperform -> Outperform
2024-08-08 Canaccord Genuity Initiate Buy
2024-07-31 Barrington Research Maintains Outperform -> Outperform
2024-04-25 BMO Capital Maintains Outperform -> Outperform
2024-04-24 Barrington Research Maintains Outperform -> Outperform
2024-04-17 Barrington Research Maintains Outperform -> Outperform
2024-01-29 Citigroup Maintains Buy -> Buy
2024-01-25 BMO Capital Maintains Outperform -> Outperform
2024-01-24 Barrington Research Maintains Outperform -> Outperform
2024-01-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight